SLX9 is known to interact with the 5.8S rRNA, a component of the small subunit of the ribosome, suggesting its involvement in early steps of ribosome biogenesis. It has been implicated in the processing and modification of rRNA, which are essential steps in the formation of functional ribosomes.In addition to its role in ribosome biogenesis, SLX9 has been linked to the regulation of cell cycle progression and cellular proliferation. Its precise mechanisms in these processes are still being elucidated, but studies have suggested that SLX9 may contribute to the control of cell division and proliferation through its involvement in ribosome biogenesis and potentially through additional interactions with cellular factors.
Furthermore, SLX9 has been associated with DNA damage response pathways. Research has indicated its potential involvement in maintaining genome stability and responding to DNA damage, suggesting that it may have broader functions beyond ribosome biogenesis.Understanding the functions of SLX9 is important not only for fundamental cellular biology but also for potential implications in human health and disease. Dysregulation of ribosome biogenesis factors such as SLX9 has been linked to various diseases, including cancer and developmental disorders.Continued research into SLX9 and its interactions with other cellular components will likely provide further insights into its specific roles in ribosome biogenesis, cell cycle regulation, genome stability, and potential contributions to human health and disease.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Binds to DNA and inhibits RNA polymerase, affecting RNA synthesis and potentially ribosome biogenesis. | ||||||
CX-5461 | 1138549-36-6 | sc-507275 | 5 mg | $245.00 | ||
Inhibits RNA Polymerase I, affecting ribosomal RNA synthesis and potentially impacting ribosome biogenesis. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
An mTOR inhibitor, can influence ribosome biogenesis and protein synthesis pathways. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
Affects RNA processing and function, potentially influencing ribosome biogenesis. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $69.00 $266.00 | 8 | |
Inhibits inosine monophosphate dehydrogenase, affecting nucleotide synthesis and potentially ribosome biogenesis. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Inhibits RNA Polymerase II, which could impact RNA synthesis and ribosome biogenesis. | ||||||
Homoharringtonine | 26833-87-4 | sc-202652 sc-202652A sc-202652B | 1 mg 5 mg 10 mg | $52.00 $125.00 $182.00 | 11 | |
Inhibits protein synthesis at the ribosome, potentially impacting ribosome biogenesis indirectly. | ||||||
Puromycin dihydrochloride | 58-58-2 | sc-108071 sc-108071B sc-108071C sc-108071A | 25 mg 250 mg 1 g 50 mg | $42.00 $214.00 $832.00 $66.00 | 394 | |
Inhibits protein synthesis by causing premature chain termination during translation. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Affects lysosomal function and autophagy, which can indirectly influence ribosome biogenesis. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Inhibits peptide bond formation at the ribosome, affecting protein synthesis. | ||||||